Clinical Trial Update: Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health [NA]

View source ↗

Summary

Massachusetts General Hospital is conducting a clinical trial to assess how disclosing a polygenic risk score for coronary artery disease affects cardiovascular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Coronary Artery Disease | NA | Status: RECRUITING